CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Clinical trials for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL explained in plain language.
Never miss a new study
Get alerted when new CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL trials appear
Sign up with your email to follow new studies for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common gout drug slow heart disease in people with a gene variant?
Disease control Not yet recruitingThis study tests whether the drug colchicine can slow the buildup of plaque in heart arteries for people who have a specific genetic change called TET2-CHIP. About 120 adults who recently had a heart attack will receive colchicine or a placebo alongside their usual care. The goal…
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated May 17, 2026 03:30 UTC
-
5,000 patients to help unravel Immune-Blood link
Knowledge-focused Not yet recruitingThis study will follow 5,000 adults with immune system issues to see how often they also have clonal hematopoiesis (a type of blood cell change) or related blood diseases like VEXAS syndrome. Researchers will track new cases over time to better understand these conditions. No tre…
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC